Joint venture with NextLevel Assistive Technology
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Control Bionics Ltd. has announced a strategic joint venture with NextLevel Assistive Technology to enhance its iOS speech-generating device platform in the United States. The agreement allows Control Bionics to manufacture, distribute, and sell new iOS-based speech-generating devices while acting as the FDA Manufacturer of Record. This partnership aims to leverage NextLevel's designs and Control Bionics' distribution network to tap into the growing US augmentative and assistive communication market. Control Bionics is currently negotiating with multiple US distributors to expand its market presence without significant capital investment.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Control Bionics
- Half Yearly Report and Accounts
- PRC-Saltillo - Distribution Agreement
- Quarterly Activities/Appendix 4C Cash Flow Report
- Tobii Dynavox - Distribution Partnership
- Acquisition of Full Ownership of Neuro Elite Athletics
Later from Control Bionics
- German Statutory Reimbursement Listing for NeuroNode
- Commercial Momentum Presentation
- Pause in Trading
- Completion of Placement
- Commercial momentum builds across both platform pillars
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics